TRYPSIN II

Neova Technologies Inc.

TRYPSIN II is our low-endotoxin preparation with reduced chymotrypsin activity. This can be used as an alternative to TRYPSIN IV (link). TRYPSIN II is ideally suited to the food industry, as high chymotrypsin activity can hydrolyse aromatic amino acids which contribute to food flavour profiles. This hydrolysis can impact negatively upon organoleptic properties when used in food processing, imparting an ‘off-taste’.

Applications

Trypsin  has extensive applications due to its fundamental physiological function which is the same natural process as the human digestive system.  Trypsin  has effective uses in foods and  pharmaceuticals, as well as in tissue dissociation, cell harvesting, and microbiological media. TRYPSIN II is ideally suited for functional food and food processing applications. These include improving digestibility, reducing allergenicity (particularly milk-derived casein and whey), meat tenderisation, whey protein hydrolysis, and improvement of whip and taste.

Specification

Activity reported as USP units/mg

Trypsin: ≥ 450 U/mg

Chymotrypsin: ≤ 75 U/mg

Endotoxin: ≤ 10 EU/mg

 

Trypsin Grades

Medical, Pharmaceutical, and Research


 

 

Application Suitability TRYPSIN VI TRYPSIN IV TRYPSIN II TRYPSIN I TRYPSIN 1:250 TRYPSIN SE
Pancreatin
Vaccine Production            
Cell and Tissue Culture            
Mass Spectroscopy            
Diabetes & Ophthalmic research            
USP / EP guideline conformance            
Reduce Oedema and Bruising            
Enteral Feeding            

 

Food Processing, Infant Formula & Dietary Supplements


 

 

Application Suitability TRYPSIN VI TRYPSIN IV TRYPSIN II TRYPSIN I TRYPSIN 1:250 TRYPSIN SE
Pancreatin
Whey Protein Hydrolysis            
Production of Infant Formula            
Production of Hypoallergenic Infant Formula            
Food Processing            
Meat and Seafood Tenderisation            
Enhancement of Food Digestibility            
Dietary Supplementation            
Functional Foods            

 

 

Neova Technologies Inc., part of Bioseutica® group, has been extracting pancreatic enzymes for over 25 years. As one of the largest global manufacturers of porcine-derived enzymes, we have the experience to tailor our preparations to the exacting specifications of our customers. Contact us using the form below to discuss your specific requirements.

 

No Warranty: The information contained herein is provided in good faith and, to the best of our knowledge, is true and correct. However, no warranty or guarantee is implied or inferred and the information may be subject to change without prior notice. Neova Technologies Inc.’s products are sold with the understanding that the purchaser will conduct tests to determine the suitability of these products for their particular use.

Show in grid
On

More information

Address
Privacy